Literature DB >> 23047355

The need for rigorous evidence on medication use in preterm infants: is it time for a neonatal rule?

Jonathan M Davis1, Edward M Connor, Alastair J J Wood.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23047355     DOI： 10.1001/jama.2012.12883

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

1.  Drug utilisation profile in the neonatal unit of a university hospital: a prospective observational study in Brazil.

Authors:  Adriana Cristina de Souza Gonçalves; Adriano Max Moreira Reis; Ana Carolina Marçal Gusmão; Maria Cândida Ferrarez Bouzada
Journal:  Int J Clin Pharm       Date:  2015-04-02

Review 2.  Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors:  Cindy T McEvoy; Lucky Jain; Barbara Schmidt; Steven Abman; Eduardo Bancalari; Judy L Aschner
Journal:  Ann Am Thorac Soc       Date:  2014-04

3.  Pharmacological options for BPD prevention: steps for better clinical trial design.

Authors:  R M Viscardi
Journal:  J Perinatol       Date:  2014-09       Impact factor: 2.521

4.  Sponsors meet scientists to speed pediatric medicines development.

Authors:  Jonathan M Davis; William E Smoyer; Edward M Connor; W Charles Huskins; Cindy Pastern; Mary Purucker; Elisabeth C Schrader; Cynthia R Jackson; Frederick J Kaskel; Steven Hirschfeld
Journal:  Sci Transl Med       Date:  2015-03-18       Impact factor: 17.956

5.  New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products.

Authors:  Ann-Katrine Birkelund Mogensen; Helle Christiansen; Marie Louise De Bruin; Christine Erikstrup Hallgreen
Journal:  Paediatr Drugs       Date:  2022-08-13       Impact factor: 3.930

Review 6.  The Natural History of Bronchopulmonary Dysplasia: The Case for Primary Prevention.

Authors:  Cindy T McEvoy; Judy L Aschner
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

Review 7.  Strategic biomarkers for drug development in treating rare diseases and diseases in neonates and infants.

Authors:  Jane P F Bai; Jeffrey S Barrett; Gibert J Burckart; Bernd Meibohm; Hari Cheryl Sachs; Lynne Yao
Journal:  AAPS J       Date:  2013-01-19       Impact factor: 4.009

Review 8.  Anesthetic use in newborn infants: the urgent need for rigorous evaluation.

Authors:  Viviane G Nasr; Jonathan M Davis
Journal:  Pediatr Res       Date:  2015-03-19       Impact factor: 3.756

9.  Key Challenges in the Search for Innovative Drug Treatments for Special Populations. Converging Needs in Neonatology, Pediatrics, and Medical Genetics.

Authors:  Stuart MacLeod
Journal:  Children (Basel)       Date:  2017-08-04

10.  Drug versus placebo randomized controlled trials in neonates: A review of ClinicalTrials.gov registry.

Authors:  Emilie Desselas; Claudia Pansieri; Stephanie Leroux; Maurizio Bonati; Evelyne Jacqz-Aigrain
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.